Activity of Vincristine and Irinotecan in Diffuse Anaplastic Wilms Tumor and Therapy Outcomes of Stage II to IV Disease: Results of the Children’s Oncology Group AREN0321 Study

PURPOSE: AREN0321 evaluated the activity of vincristine and irinotecan (VI) in patients with newly diagnosed diffuse anaplastic Wilms tumor (DAWT) and whether a regimen containing carboplatin (regimen UH1) in addition to regimen I agents used in the National Wilms Tumor Study 5 (NWTS-5; vincristine,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Daw, Najat C., Chi, Yueh-Yun, Kalapurakal, John A., Kim, Yeonil, Hoffer, Fredric A., Geller, James I., Perlman, Elizabeth J., Ehrlich, Peter F., Mullen, Elizabeth A., Warwick, Anne B., Grundy, Paul E., Paulino, Arnold C., Gratias, Eric, Ward, Deborah, Anderson, James R., Khanna, Geetika, Tornwall, Brett, Fernandez, Conrad V., Dome, Jeffrey S.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2020
Assuntos:
ORIGINAL REPORTS
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213587/
https://ncbi.nlm.nih.gov/pubmed/32134700
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.19.01265
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados